Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3419340 | Revue de Pneumologie Clinique | 2016 | 8 Pages |
Abstract
Bronchial carcinoids are uncommon pulmonary neoplasms and represent 1Â to 2Â % of all lung tumors. In early stage of disease, the mainstay and only curative treatment is surgery. Bronchial carcinoids are generally regarded as low-grade carcinomas and metastatic dissemination is unusual. The management of the metastatic stage is not currently standardized due to a lack of relevant studies. As bronchial carcinoids and in particular their metastatic forms are rare, we apply treatment strategies that have been evaluated in gastrointestinal and pancreatic neuroendocrine tumors. However, bronchial carcinoids have their own characteristic. A specific therapeutic feature of these metastatic tumors is that they require a dual approach: both anti-secretory for the carcinoid syndrome, and anti-tumoral.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
K. Bouledrak, T. Walter, P.J. Souquet, C. Lombard-Bohas,